Cumulative incidences of relapse by treatment arm and AML risk. Cumulative incidence curves for relapse are shown by treatment arm (A) and AML risk according to ELN 2022 criteria (B) for the PP population with treatment success. Time 0 marks CR assessment on day 56 after transplant. Adv.w/o, adverse ELN 2022 risk without TP53 mutation.